Literature DB >> 12892158

Weekly oral vitamin K prophylaxis in Denmark.

K N Hansen1, M Minousis, F Ebbesen.   

Abstract

AIM: To evaluate oral vitamin K prophylaxis at birth by giving 2 mg phytomenadione, followed by weekly oral vitamin K prophylaxis; 1 mg was administered by the parents until 3 mo of age.
METHODS: A total of 507850 live babies were born in Denmark during the study period, November 1992 to June 2000. Of these infants, 78% and 22% received oral and intra-muscular prophylaxis, respectively; i.e. about 396000 neonates received oral prophylaxis at birth. Weekly oral prophylaxis was recommended for all infants as long as they were mainly breastfed. A survey of possible cases of vitamin K deficiency bleeding (VKDB) was carried out by repeated questionnaires to all Danish paediatric departments and by checking the National Patient Register.
RESULTS: No cases of VKDB were revealed, i.e. the incidence was 0-0.9:100000 (95% CI). The questionnaires were used to evaluate compliance with the regimen. Parents of 274 infants participated. A dose of vitamin K was regarded as having been given if the infant received a drop of vitamin K or was mostly formula-fed that week, and the prophylaxis was regarded as completed if the infant had received at least 9 doses. Compliance was good, with 94% of the infants completing the course of prophylaxis.
CONCLUSION: Weekly oral vitamin K supplementation during the first 3 mo of life was an efficient prophylaxis against VKBD. Parental compliance with the regimen was good.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12892158

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  13 in total

1.  Neonatal vitamin K prophylaxis in Great Britain and Ireland: the impact of perceived risk and product licensing on effectiveness.

Authors:  Alison Busfield; Andrew McNinch; John Tripp
Journal:  Arch Dis Child       Date:  2007-05-30       Impact factor: 3.791

2.  Vitamin K deficiency bleeding: the readiness is all.

Authors:  Paul Clarke; Martin J Shearer
Journal:  Arch Dis Child       Date:  2007-05-23       Impact factor: 3.791

Review 3.  Refusal of Intramuscular Vitamin K by Parents of Newborns: A Review.

Authors:  Jaspreet Loyal; Eugene D Shapiro
Journal:  Hosp Pediatr       Date:  2020-02-04

4.  Refusal of Vitamin K by Parents of Newborns: A Qualitative Study.

Authors:  Jaspreet Loyal; Theresa R Weiss; Jessica H Cheng; Laura R Kair; Eve Colson
Journal:  Acad Pediatr       Date:  2019-04-11       Impact factor: 3.107

5.  Intracranial bleeding due to vitamin K deficiency: advantages of using a pediatric intensive care registry.

Authors:  Désirée Y Visser; Nicolaas J Jansen; Marloes M Ijland; Tom J de Koning; Peter M van Hasselt
Journal:  Intensive Care Med       Date:  2011-03-11       Impact factor: 17.440

Review 6.  Vitamin K, an update for the paediatrician.

Authors:  Myriam Van Winckel; Ruth De Bruyne; Saskia Van De Velde; Stephanie Van Biervliet
Journal:  Eur J Pediatr       Date:  2008-11-04       Impact factor: 3.183

7.  Vitamin K deficiency bleeding in Great Britain and Ireland: British Paediatric Surveillance Unit Surveys, 1993 94 and 2001-02.

Authors:  Andrew McNinch; Alison Busfield; John Tripp
Journal:  Arch Dis Child       Date:  2007-05-30       Impact factor: 3.791

8.  Oral Vitamin K Prophylaxis in Newborns: A Survey of Clinician Opinions and Practices.

Authors:  Jessica H Cheng; Jaspreet Loyal; Kelly E Wood; Laura R Kair
Journal:  Hosp Pediatr       Date:  2020-01-06

9.  The impact of national and international guidelines on newborn care in the nurseries of Piedmont and Aosta Valley, Italy.

Authors:  Andrea Guala; Roberta Guarino; Mauro Zaffaroni; Claudio Martano; Claudio Fabris; Guido Pastore; Gianni Bona
Journal:  BMC Pediatr       Date:  2005-12-05       Impact factor: 2.125

10.  Incidence of late vitamin K deficiency bleeding in newborns in the Netherlands in 2005: evaluation of the current guideline.

Authors:  Marloes M Ijland; Rob Rodrigues Pereira; Elisabeth A M Cornelissen
Journal:  Eur J Pediatr       Date:  2007-03-01       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.